Robert F. Kennedy Jr., the Trump administration’s pick to lead the Department of Health and Human Services, faced renewed criticism this week as Democrats in a Senate committee hearing and multiple public letters called for his resignation amid a broader fight over proposed changes to federal dietary guidance and public-health priorities.
At the Oversight Committee hearing, Democratic lawmakers repeatedly questioned Kennedy’s fitness for the cabinet post and used sharply critical language. The hearing followed an open letter from nine former Centers for Disease Control and Prevention leaders and a separate letter from roughly 1,000 current and former HHS employees urging Kennedy to step down, according to those documents and public statements from lawmakers.
Kennedy, whose tenure is closely associated with the administration’s “Make America Healthy Again” (MAHA) agenda, has pushed for a re-evaluation of federal dietary guidance and an emphasis on addressing chronic disease, food safety and vaccine policy. Supporters say the initiative seeks to reduce childhood obesity and chronic illness by revising nutrition recommendations and targeting what they describe as entrenched industry influence. Critics contend the proposals risk politicizing science and could stoke vaccine skepticism and other public-health concerns.
The dispute has hinged in part on the Dietary Guidelines for Americans, 2025–2030, released by the Biden administration in December after the presidential election. Kennedy and MAHA allies have criticized the guidelines as influenced by food industry interests and ideological priorities, and the MAHA Commission held a closed-door meeting in March that resolved to revisit the guidance, according to a statement from Agriculture Secretary Brooke Rollins released after the meeting. "We will make certain the 2025–2030 Guidelines are based on sound science, not political science," Rollins said in the statement.
Independent analyses cited during the debate have focused attention on the Dietary Guidelines Advisory Committee (DGAC), which produced a lengthy advisory report. A report from the nonprofit public-health research group U.S. Right to Know assessed the DGAC as having multiple potential conflicts of interest, saying 13 of 20 committee members had "high-risk, medium-risk or possible conflicts" with food, pharmaceutical and weight-loss companies or industry groups. A 2022 study published in the Journal of Public Health Nutrition found that a large majority of committee members had ties to food or pharmaceutical companies, including firms named in the paper such as Kellogg and Abbott.
Authors of the Journal of Public Health Nutrition paper argued that such conflicts can undermine transparency and public trust in the guideline process. "Trustworthy dietary guidelines result from a transparent, objective and science-based process," they wrote, calling for mechanisms to make potential conflicts publicly available.
Those findings have been cited by Kennedy and other MAHA supporters as justification for overhauling the advisory process. Kennedy has publicly criticized the 2025–2030 guidelines, saying they reflect the influence of food-processing interests, and MAHA advocates have signaled plans to move federal guidance toward increased emphasis on animal fats and full-fat dairy while discouraging some seed oils, ultra-processed foods and certain additives.
Opponents say the proposed shifts risk reversing longstanding public-health messages and could undermine efforts to maintain broad vaccination coverage and other preventive measures. During the Senate hearing and in public commentary, several Democratic lawmakers and public-health advocates described Kennedy's record and rhetoric on vaccines as a concern for the agency charged with protecting public health. Some Republican figures and commentators have also expressed wariness; others have defended Kennedy’s push to address chronic disease.
The debate has extended into partisan rhetoric. Some commentators and elected officials have linked recent measles outbreaks and other communicable-disease incidents to policy choices and migration patterns; others point to long-standing factors such as local vaccination rates and access to health services.
The standoff over the dietary guidelines, the composition and independence of advisory panels, and Kennedy’s leadership of HHS crystallizes broader tensions over the role of industry in public-health policymaking and the intersection of science and politics. Congressional oversight, statements from former agency leaders and the internal reaction from HHS employees signal that the dispute is likely to remain a central issue in health policy discussions as the administration moves to implement its MAHA priorities.
Officials from HHS and the MAHA Commission have said they will proceed with reviews and potential revisions of federal nutrition guidance. Opponents and external experts have called for greater transparency around advisory-panel relationships with industry and for careful consideration of the scientific evidence and public-health implications of any policy changes. Congressional hearings and public commentary are expected to continue as the administration outlines specific regulatory and guidance proposals.